Cite
HARVARD Citation
Morand, E. et al. (n.d.). PO.6.135 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW). Lupus science & medicine. p. A103. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morand, E. et al. (n.d.). PO.6.135 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and phase II study design in patients with SLE and/or CLE (WILLOW). Lupus science & medicine. p. A103. [Online].